Announcement
01 Jan 2022
In 2022, the Chinese listed company Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced it had received USD 71 million of government subsidies.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
01 Jan 2022
Revocation date:
No revocation date
Updated: 01 Jan 2022
Financial grant
In force
In 2022, the Shanghai-listed firm Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (also known as GYBYS) disclosed in its stock exchange filings the receipt of approximately USD 71 million...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.